Vascular Responses to Endothelin-1 in Conscious Rats: Modulation by Endogenous Nitric Oxide

作者: Janos G. Filep , Alain Fournier , Eva Foldes-Filep

DOI: 10.1007/978-1-4615-1903-4_17

关键词: Blood flowEndothelin 1Vascular permeabilityNitric oxideCoronary circulationEndocrinologyNeutrophil granulocyteEndotheliumEvans BlueInternal medicineChemistry

摘要: The vascular endothelium is an active site for the production of many substances essential in regulation tone and reactivity. For instance, endothelial cells release endothelium-derived relaxing factor (EDRF), now characterized as nitric oxide (NO) (Ignarro et al., 1987; Palmer 1987) endothelin-1 (ET-1) (Yanagisawa 1988). continuous NO from (Ignarro, 1989) appears to play important role intrinsic modulator tone, blood flow microvascular permeability mesenteric (Kubes Granger, 1992) coronary circulation (Filep 1993b).

参考文章(25)
Michael S. Simonson, Michael J. Dunn, The molecular mechanisms of cardiovascular and renal regulation by endothelin peptides. Journal of Laboratory and Clinical Medicine. ,vol. 119, pp. 622- 639 ,(1992) , 10.5555/URI:PII:002221439290286T
Allan M. Lefer, Philip S. Tsao, David J. Lefer, Xin‐Liang Ma, Role of endothelial dysfunction in the pathogenesis of reperfusion injury after myocardial ischemia. The FASEB Journal. ,vol. 5, pp. 2029- 2034 ,(1991) , 10.1096/FASEBJ.5.7.2010056
G Chaudhuri, H M Vargas, L J Ignarro, J M Cuevas, Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. Journal of Pharmacology and Experimental Therapeutics. ,vol. 257, pp. 1208- 1215 ,(1991)
Richard M.J. Palmer, Daryl D. Rees, David S. Ashton, Salvador Moncada, L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation Biochemical and Biophysical Research Communications. ,vol. 153, pp. 1251- 1256 ,(1988) , 10.1016/S0006-291X(88)81362-7
P.K. Moore, O.A. Al-Swayeh, N.W.S. Chong, R.A. Evans, A. Gibson, l-NG-nitro arginine (l-NOARG), a novel, l-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro British Journal of Pharmacology. ,vol. 99, pp. 408- 412 ,(1990) , 10.1111/J.1476-5381.1990.TB14717.X
János G. Filep, Martin G. Sirois, Anne Rousseau, Alain Fournier, Pierre Sirois, Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. British Journal of Pharmacology. ,vol. 104, pp. 797- 804 ,(1991) , 10.1111/J.1476-5381.1991.TB12509.X
M.W Radomski, R.M.J Palmer, S Moncada, Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. The Lancet. ,vol. 330, pp. 1057- 1058 ,(1987) , 10.1016/S0140-6736(87)91481-4
Kazuo Aisaka, Steven S. Gross, Owen W. Griffith, Roberto Levi, L-arginine availability determines the duration of acetylcholine-induced systemic vasodilatation in vivo Biochemical and Biophysical Research Communications. ,vol. 163, pp. 710- 717 ,(1989) , 10.1016/0006-291X(89)92281-X
R. M. J. Palmer, A. G. Ferrige, S. Moncada, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature. ,vol. 327, pp. 524- 526 ,(1987) , 10.1038/327524A0